Nu Skin Enterprises, Inc. (NYSE:NUS) President Ryan S. Napierski sold 6,933 shares of the stock in a transaction on Tuesday, October 10th. The stock was sold at an average price of $64.00, for a total value of $443,712.00. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Shares of Nu Skin Enterprises, Inc. (NYSE NUS) traded down 0.59% during trading on Wednesday, hitting $62.80. The stock had a trading volume of 581,104 shares. The stock has a 50 day moving average price of $61.31 and a 200-day moving average price of $59.16. The stock has a market capitalization of $3.32 billion, a price-to-earnings ratio of 21.00 and a beta of 1.40. Nu Skin Enterprises, Inc. has a one year low of $46.35 and a one year high of $65.98.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Wednesday, August 2nd. The company reported $0.77 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.08. The business had revenue of $550.10 million for the quarter, compared to analyst estimates of $548.09 million. Nu Skin Enterprises had a return on equity of 24.14% and a net margin of 7.53%. Nu Skin Enterprises’s quarterly revenue was down 8.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.79 EPS. On average, equities research analysts predict that Nu Skin Enterprises, Inc. will post $3.23 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 13th. Investors of record on Friday, August 25th were given a dividend of $0.36 per share. The ex-dividend date of this dividend was Wednesday, August 23rd. This represents a $1.44 dividend on an annualized basis and a yield of 2.29%. Nu Skin Enterprises’s dividend payout ratio is currently 48.81%.

ILLEGAL ACTIVITY WARNING: “Ryan S. Napierski Sells 6,933 Shares of Nu Skin Enterprises, Inc. (NUS) Stock” was published by American Banking News and is the property of of American Banking News. If you are reading this news story on another website, it was stolen and republished in violation of U.S. and international trademark and copyright legislation. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/10/11/ryan-s-napierski-sells-6933-shares-of-nu-skin-enterprises-inc-nus-stock.html.

Hedge funds have recently modified their holdings of the stock. US Bancorp DE grew its position in Nu Skin Enterprises by 3.3% during the 2nd quarter. US Bancorp DE now owns 2,032 shares of the company’s stock worth $128,000 after acquiring an additional 65 shares during the last quarter. Independent Portfolio Consultants Inc. grew its position in Nu Skin Enterprises by 14.9% during the 2nd quarter. Independent Portfolio Consultants Inc. now owns 2,730 shares of the company’s stock worth $172,000 after acquiring an additional 355 shares during the last quarter. CENTRAL TRUST Co bought a new stake in shares of Nu Skin Enterprises in the 2nd quarter valued at about $187,000. Pillar Pacific Capital Management LLC bought a new stake in shares of Nu Skin Enterprises in the 2nd quarter valued at about $202,000. Finally, Ronald Blue & Co. LLC bought a new stake in shares of Nu Skin Enterprises in the 2nd quarter valued at about $207,000. Institutional investors and hedge funds own 79.25% of the company’s stock.

Several analysts have recently commented on NUS shares. Pivotal Research restated a “buy” rating and set a $80.00 target price (up previously from $65.00) on shares of Nu Skin Enterprises in a report on Thursday, June 22nd. Zacks Investment Research cut Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Bank of America Corporation increased their target price on Nu Skin Enterprises from $53.00 to $57.00 and gave the stock an “underperform” rating in a report on Monday, July 10th. BidaskClub cut Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Finally, Stifel Nicolaus set a $50.00 target price on Nu Skin Enterprises and gave the stock a “sell” rating in a report on Thursday, August 3rd. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and four have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $62.00.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Insider Buying and Selling by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.